162 related articles for article (PubMed ID: 23658483)
21. DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells.
Jing W; Song N; Liu Y; Qu X; Hou K; Yang X; Che X
Mol Med Rep; 2018 Jan; 17(1):117-124. PubMed ID: 29115606
[TBL] [Abstract][Full Text] [Related]
22. Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo.
Banerjee S; Kong D; Azmi AS; Wang Z; Ahmad A; Sethi S; Sarkar FH
Int J Cancer; 2011 Mar; 128(5):1240-50. PubMed ID: 20824697
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.
Dosch JS; Ziemke EK; Shettigar A; Rehemtulla A; Sebolt-Leopold JS
Cancer Res; 2015 Nov; 75(21):4582-92. PubMed ID: 26359451
[TBL] [Abstract][Full Text] [Related]
24. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line.
Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Umebayashi M; Morisaki T; Hasumi K
Anticancer Res; 2016 Feb; 36(2):653-7. PubMed ID: 26851020
[TBL] [Abstract][Full Text] [Related]
25. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
26. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].
An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984
[TBL] [Abstract][Full Text] [Related]
27. 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.
Banerjee S; Wang Z; Kong D; Sarkar FH
Cancer Res; 2009 Jul; 69(13):5592-600. PubMed ID: 19531648
[TBL] [Abstract][Full Text] [Related]
28. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
[TBL] [Abstract][Full Text] [Related]
29. A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
Rajeshkumar NV; Rasheed ZA; García-García E; López-Ríos F; Fujiwara K; Matsui WH; Hidalgo M
Mol Cancer Ther; 2010 Sep; 9(9):2582-92. PubMed ID: 20660600
[TBL] [Abstract][Full Text] [Related]
30. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors.
May JP; Ernsting MJ; Undzys E; Li SD
Mol Pharm; 2013 Dec; 10(12):4499-508. PubMed ID: 24152292
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression.
Guo Z; Wang F; Di Y; Yao L; Yu X; Fu D; Li J; Jin C
Int J Nanomedicine; 2018; 13():4869-4880. PubMed ID: 30214194
[TBL] [Abstract][Full Text] [Related]
32. Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
Venkatesha VA; Parsels LA; Parsels JD; Zhao L; Zabludoff SD; Simeone DM; Maybaum J; Lawrence TS; Morgan MA
Neoplasia; 2012 Jun; 14(6):519-25. PubMed ID: 22787433
[TBL] [Abstract][Full Text] [Related]
33. uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors.
Sobrevals L; Mato-Berciano A; Urtasun N; Mazo A; Fillat C
Stem Cell Res; 2014 Jan; 12(1):1-10. PubMed ID: 24141108
[TBL] [Abstract][Full Text] [Related]
34. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
[TBL] [Abstract][Full Text] [Related]
35. Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells.
Kobayashi T; Shimura T; Yajima T; Kubo N; Araki K; Wada W; Tsutsumi S; Suzuki H; Kuwano H; Raz A
Clin Exp Metastasis; 2011 Apr; 28(4):367-76. PubMed ID: 21331750
[TBL] [Abstract][Full Text] [Related]
36. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer.
Li YJ; Wu JY; Wang JM; Hu XB; Cai JX; Xiang DX
Acta Biomater; 2020 Jan; 101():519-530. PubMed ID: 31629893
[TBL] [Abstract][Full Text] [Related]
37. HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer.
Jung KH; Yan HH; Fang Z; Son MK; Lee H; Hong S; Hong SS
Int J Oncol; 2014 Jul; 45(1):311-21. PubMed ID: 24819705
[TBL] [Abstract][Full Text] [Related]
38. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence.
Xia G; Zhang H; Cheng R; Wang H; Song Z; Deng L; Huang X; Santos HA; Cui W
Adv Healthc Mater; 2018 Sep; 7(18):e1800593. PubMed ID: 30062854
[TBL] [Abstract][Full Text] [Related]
39. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway.
Wang Y; Zhou Y; Jia G; Han B; Liu J; Teng Y; Lv J; Song Z; Li Y; Ji L; Pan S; Jiang H; Sun B
Biochem Pharmacol; 2014 Apr; 88(3):322-33. PubMed ID: 24522113
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.
Zhang Z; Han H; Rong Y; Zhu K; Zhu Z; Tang Z; Xiong C; Tao J
J Exp Clin Cancer Res; 2018 Nov; 37(1):291. PubMed ID: 30486896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
